| May 1st, 2017 12:08 PM | |
| Vishal Kotkar | Re: dcth nda According to me yea FDA has accepted the Delcath Systems, Inc New Drug Application and here I will get details of company. The Delcath Systems, Inc is a publicly-traded specialty pharmaceutical and medical device company helps to develops percutaneous perfusion technologies of high-dose chemotherapeutic agents to specific organs or regions of the body. Ongoing Clinical Trials Phase 3 FOCUS Trial in Hepatic Dominant Ocular Melanoma Phase 2 Clinical Trials in Hepatocellular Carcinoma (HCC) and Intrahepatic Cholangiocarcinoma (ICC) Board of Director Roger G. Stoll, PH.D. Executive Chairman Harold S. Koplewicz, M.D. Director William D. Rueckert Director Jennifer Simpson, PhD., M.S.N., C.R.N.P. Director Dr. Marco Taglietti Director Management Jennifer Simpson, PhD., M.S.N., C.R.N.P. President and Chief Executive Officer John Purpura Executive Vice President Regulatory Affairs, Quality Assurance Barbra C. Keck Senior Vice President, Finance Address:- Delcath Systems, Inc 1633 Broadway 22nd Floor, Suite C New York, NY 10019 Phone:- (212) 489-2100 |
| May 1st, 2017 12:07 PM | |
| Unregistered | Re: dcth nda Would you please tell me details of Delcath Systems, Inc if FDA accepted New Drug Application of company so that I can go through it? |
| January 19th, 2016 01:49 PM | |
| nilesh | dcth nda Discuss about dcth nda here. Welcome to Courses.ind.in and this page is for dcth nda discussion. If you are looking for information on dcth nda then ask your question is as much details as possible in the “Reply” box provided below. The more detailed your question will be, the more easy will it be for our experts to answers your query. And if you have any updated or latest information on dcth nda, then please share you knowledge with our experts in the “Reply” box below. Your reply will be published here and your knowledge can help many people. Thanks for stopping by at Courses.ind.in. Please visit again. |
